2350

    543264

    NURECA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    NURECA LIMITED Share Price Today

    NURECA LIMITED is currently trading at ₹274.09, up by ₹2.51 from the previous close. The stock touched an intraday high of ₹279.90 and a low of ₹261.20 during the latest trading session. Over the past one year, NURECA LIMITED has delivered a loss of 4.65%, while the stock has gained 15.17% in the last one month.

    NURECA LIMITED performance

    Today’s low Today’s high
    ₹ 261.20 ₹ 279.90
    ₹ 271.27
    52 week low 52 week high
    ₹ 204.00 ₹ 343.00
    ₹ 271.27
    Open Price ₹ 274.80
    Prev. Close ₹ 271.58
    Volume (Shares) 22633.00
    Total traded value ₹ 61.39
    Upper Circuit ₹ 325.89
    Lower Circuit ₹ 217.27
    info

    Investment Returns

    Over 1 Month 15.17% Over 3 Months 3.74% Over 6 Months -12.97% Over 1 Year -4.65%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    NURECA LIMITED fundamentals


    • Market cap (Cr) 258.80
    • P/E Ratio (TTM) 878.06
    • Beta 1.13
    • Book Value / share 185.66
    • Return on equity 0.16%
    • EPS (TTM) 0.32
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -6.63
    info icon alternate text
    • Market cap (Cr) 258.20
    • P/E Ratio (TTM) 878.06
    • Beta 1.10
    • Book Value / share 185.66
    • Return on equity 0.16%
    • EPS (TTM) 0.32
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -6.63
    info icon alternate text

    NURECA LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 35.41
    Operating Expense 42.62
    Net Profit -6.63
    Net Profit Margin (%) -18.72
    Earnings Per Share (EPS) -6.95
    EBITDA -5.48
    Effective Tax Rate (%) -7.64
    Particulars DEC 2025 (Values in Cr)
    Revenue 39.64
    Operating Expense 37.88
    Net Profit 3.23
    Net Profit Margin (%) 8.14
    Earnings Per Share (EPS) 3.39
    EBITDA 4.68
    Effective Tax Rate (%) 20.24
    Particulars SEP 2025 (Values in Cr)
    Revenue 37.84
    Operating Expense 36.12
    Net Profit 3.14
    Net Profit Margin (%) 8.29
    Earnings Per Share (EPS) 3.14
    EBITDA 5.00
    Effective Tax Rate (%) 23.60
    Particulars JUN 2025 (Values in Cr)
    Revenue 34.32
    Operating Expense 36.08
    Net Profit 0.55
    Net Profit Margin (%) 1.60
    Earnings Per Share (EPS) 0.55
    EBITDA 1.51
    Effective Tax Rate (%) 33.73
    Particulars MAR 2025 (Values in Cr)
    Revenue 31.75
    Operating Expense 32.25
    Net Profit 2.07
    Net Profit Margin (%) 6.51
    Earnings Per Share (EPS) 2.07
    EBITDA 2.57
    Effective Tax Rate (%) -37.99
    Particulars MAR 2026 (Values in Cr)
    Revenue 147.21
    Operating Expense 152.69
    Net Profit 0.30
    Net Profit Margin (%) 0.20
    Earnings Per Share (EPS) 0.30
    EBITDA 5.72
    Effective Tax Rate (%) 89.43
    Particulars MAR 2025 (Values in Cr)
    Revenue 114.64
    Operating Expense 127.65
    Net Profit -0.67
    Net Profit Margin (%) -0.58
    Earnings Per Share (EPS) -0.67
    EBITDA 2.81
    Effective Tax Rate (%) -45.65
    Particulars MAR 2024 (Values in Cr)
    Revenue 94.52
    Operating Expense 108.35
    Net Profit -2.44
    Net Profit Margin (%) -2.58
    Earnings Per Share (EPS) -2.44
    EBITDA -0.56
    Effective Tax Rate (%) 25.38
    Particulars MAR 2023 (Values in Cr)
    Revenue 111.90
    Operating Expense 130.02
    Net Profit -8.42
    Net Profit Margin (%) -7.52
    Earnings Per Share (EPS) -8.40
    EBITDA -8.23
    Effective Tax Rate (%) 23.17
    Particulars MAR 2022 (Values in Cr)
    Revenue 255.55
    Operating Expense 201.94
    Net Profit 45.31
    Net Profit Margin (%) 17.73
    Earnings Per Share (EPS) 45.31
    EBITDA 63.48
    Effective Tax Rate (%) 26.12
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 189.44
    ROE % 1.11
    ROCE % 3.26
    Total Debt to Total Equity 0.02
    EBITDA Margin 5.63
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 194.29
    ROE % 0.44
    ROCE % 1.29
    Total Debt to Total Equity 0.02
    EBITDA Margin 4.46
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 193.11
    ROE % -3.14
    ROCE % -4.00
    Total Debt to Total Equity 0.02
    EBITDA Margin -6.05
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 194.88
    ROE % -5.37
    ROCE % -6.26
    Total Debt to Total Equity 0.02
    EBITDA Margin -9.29
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 203.20
    ROE % 24.55
    ROCE % 32.88
    Total Debt to Total Equity 0.02
    EBITDA Margin 24.73
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 185.66
    ROE % 0.16
    ROCE % 2.05
    Total Debt to Total Equity 0.02
    EBITDA Margin 3.88
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 192.48
    ROE % -0.35
    ROCE % 0.34
    Total Debt to Total Equity 0.02
    EBITDA Margin 2.45
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 192.86
    ROE % -1.26
    ROCE % -1.42
    Total Debt to Total Equity 0.01
    EBITDA Margin -0.56
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 195.26
    ROE % -4.22
    ROCE % -5.16
    Total Debt to Total Equity 0.02
    EBITDA Margin -7.03
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 203.74
    ROE % 24.69
    ROCE % 33.01
    Total Debt to Total Equity 0.02
    EBITDA Margin 23.50
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 46.25
    Total Assets 209.97
    Total Liabilities 209.97
    Total Equity 194.28
    Share Outstanding 1
    Price to Book Ratio 1.09
    Return on Assets (%) 0.40
    Return on Capital (%) 0.43
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 45.30
    Total Assets 205.16
    Total Liabilities 205.16
    Total Equity 193.11
    Share Outstanding 1
    Price to Book Ratio 1.32
    Return on Assets (%) -0.87
    Return on Capital (%) -0.93
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 70.96
    Total Assets 206.58
    Total Liabilities 206.58
    Total Equity 194.88
    Share Outstanding 1
    Price to Book Ratio 1.54
    Return on Assets (%) -3.99
    Return on Capital (%) -4.23
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 84.35
    Total Assets 219.13
    Total Liabilities 219.13
    Total Equity 203.19
    Share Outstanding 1
    Price to Book Ratio 6.69
    Return on Assets (%) 20.51
    Return on Capital (%) 22.12
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 126.69
    Total Assets 185.75
    Total Liabilities 185.75
    Total Equity 163.09
    Share Outstanding 1
    Price to Book Ratio 3.69
    Return on Assets (%) 24.96
    Return on Capital (%) 27.83
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 41.35
    Total Assets 193.54
    Total Liabilities 193.54
    Total Equity 177.16
    Share Outstanding 0
    Price to Book Ratio 1.11
    Return on Assets (%) 0.15
    Return on Capital (%) 0.17
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 127.33
    Total Assets 206.15
    Total Liabilities 206.15
    Total Equity 192.47
    Share Outstanding 1
    Price to Book Ratio 1.09
    Return on Assets (%) -0.32
    Return on Capital (%) -0.34
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 45.20
    Total Assets 204.33
    Total Liabilities 204.33
    Total Equity 192.85
    Share Outstanding 1
    Price to Book Ratio 1.32
    Return on Assets (%) -1.19
    Return on Capital (%) -1.26
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 70.86
    Total Assets 206.68
    Total Liabilities 206.68
    Total Equity 195.26
    Share Outstanding 1
    Price to Book Ratio 1.54
    Return on Assets (%) -4.07
    Return on Capital (%) -4.31
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 84.18
    Total Assets 219.53
    Total Liabilities 219.53
    Total Equity 203.74
    Share Outstanding 1
    Price to Book Ratio 6.69
    Return on Assets (%) 20.63
    Return on Capital (%) 22.24
    Particulars MAR 2026 (Values in Cr)
    Net Income 4.98
    Cash from Operations 3.21
    Cash from Investing 14.49
    Cash from Financing -19.56
    Net change in Cash -1.77
    Free Cash Flow 10.04
    Particulars MAR 2025 (Values in Cr)
    Net Income 1.34
    Cash from Operations -17.70
    Cash from Investing 8.43
    Cash from Financing -0.16
    Net change in Cash -10.81
    Free Cash Flow -13.38
    Particulars MAR 2024 (Values in Cr)
    Net Income -2.54
    Cash from Operations -3.96
    Cash from Investing 17.57
    Cash from Financing -1.30
    Net change in Cash 13.56
    Free Cash Flow -2.87
    Particulars MAR 2023 (Values in Cr)
    Net Income -10.74
    Cash from Operations 14.37
    Cash from Investing -16.45
    Cash from Financing -1.50
    Net change in Cash -7.73
    Free Cash Flow 14.77
    Particulars MAR 2022 (Values in Cr)
    Net Income 60.98
    Cash from Operations 19.35
    Cash from Investing -3.08
    Cash from Financing -7.30
    Net change in Cash -8.99
    Free Cash Flow 22.75
    Particulars MAR 2026 (Values in Cr)
    Net Income 2.83
    Cash from Operations -0.10
    Cash from Investing 16.49
    Cash from Financing -18.60
    Net change in Cash -1.79
    Free Cash Flow 5.26
    Particulars MAR 2025 (Values in Cr)
    Net Income -0.46
    Cash from Operations -17.78
    Cash from Investing 8.83
    Cash from Financing -0.78
    Net change in Cash -10.77
    Free Cash Flow -13.79
    Particulars MAR 2024 (Values in Cr)
    Net Income -3.26
    Cash from Operations -4.48
    Cash from Investing 17.83
    Cash from Financing -1.27
    Net change in Cash 13.56
    Free Cash Flow -3.98
    Particulars MAR 2023 (Values in Cr)
    Net Income -10.95
    Cash from Operations 16.18
    Cash from Investing -18.30
    Cash from Financing -1.50
    Net change in Cash -7.75
    Free Cash Flow 16.42
    Particulars MAR 2022 (Values in Cr)
    Net Income 61.33
    Cash from Operations 19.78
    Cash from Investing -3.36
    Cash from Financing -7.30
    Net change in Cash -8.84
    Free Cash Flow 23.04
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    MSTC Limited 653.95 21.07 5.09 4603.81 362.00 743.00
    INFO EDGE (INDIA) LTD. 1186.00 54.25 2.02 76902.68 909.20 1484.00
    INTRASOFT TECH. LTD 78.59 9.65 0.48 128.19 54.05 119.07
    Nazara Technologies Limited 309.65 11.88 3.30 11471.45 216.00 362.50
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    MSTC Limited 653.95 20.77 5.00 4603.81 362.00 743.00
    Mitshi India Limited 14.58 104.14 4.69 12.83 11.51 17.99
    AVI PRODUCTS INDIA LIMITED 49.91 0.00 3.20 16.50 20.00 49.91
    OLYMPIA INDUSTRIES LTD. 30.00 9.40 0.40 18.07 24.45 43.00

    NURECA LIMITED shareholding pattern

    Holding
    31.39%
    68.09%
    0.27%
    0.23%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    NURECA LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    271.27 -0.11 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 261.20
    • 26 Days 245.20
    • 10 Days 251.50
    • 50 Days 248.10
    • 12 Days 249.40
    • 100 Days 255.00
    • 20 Days 245.60
    • 200 Days 261.80
    276.02 PIVOT
    First Support 264.53 First Resistance 282.88 Second Support 257.67 Second Resistance 294.37 Third Support 246.18 Third Resistance 301.23
    RSI 70.25 ADX 26.62 MACD 2.30 Williams % R -32.95 Commodity Channel Index (CCI) 329.15
    Date 2026-07-15 Week 25479.00 Same Day 26750.00 Month 11325.00
    1 Year 1.13 3 Year 0.91
    Over 1 Month
    15.17% down
    Over 1 Year
    -4.65% down
    Over 3 Months
    3.74% down
    Over 3 Years
    -8.00% down
    Over 6 Months
    -12.97% down
    Over 5 Years
    -30.00% down

    NURECA LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    24 Feb 2022 3.0 Interim 25 Feb 2022 Equity shares
    21 Sep 2021 2.0 Final 23 Sep 2021 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    24 Feb 2022 3.0 Interim 25 Feb 2022 Equity shares
    21 Sep 2021 2.0 Final 23 Sep 2021 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Nureca Ltd?

    Answer Field

    Nureca Ltd share price is for NSE ₹ 274.09 & for BSE ₹ 275.00 as on Jul 17 2026 01:49 PM.

    What is the Market Cap of Nureca Ltd Share?

    Answer Field

    The market cap of Nureca Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 17 2026 01:49 PM.

    What is the 52 Week High and Low of Nureca Ltd?

    Answer Field

    The 52 Week High and Low of Nureca Ltd for NSE is ₹ 343.00 and ₹ 204.00 and for BSE is ₹ 343.60 and ₹ 200.10.

    What is 1 year return for Nureca Ltd?

    Answer Field

    The 1 year returns on the stock has been 4.39%.

    What is the P/E Ratio of Nureca Ltd Share?

    Answer Field

    As on Jul 17 2026 01:49 PM the price-to-earnings (PE) ratio for Nureca Ltd share is 878.06.

    What is the PB ratio of Nureca Ltd Share?

    Answer Field

    As on Jul 17 2026 01:49 PM, the price-to-book (PB) ratio for Nureca Ltd share is 185.66.

    How to Buy Nureca Ltd Share?

    Answer Field

    You can trade in Nureca Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Nureca Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Nureca Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Nureca Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |